http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-109562021-B

Outgoing Links

Predicate Object
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61J1-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M39-10
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M16-183
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61J1-2048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61J1-2003
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61J1-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61J7-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61J3-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61J1-05
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61J1-20
filingDate 2017-10-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2021-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2021-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-109562021-B
titleOfInvention Connection valve structure and anesthetic dosing device
abstract Provide connection valve structure (1) and anesthetic agent dosing device. Wherein, when the valve core assembly (200) is in an open state, the sealing tube (130) is in sealing fit with the medicine inlet. In addition, the connecting ring (120), the sealing tube (130) and the drug introduction tube (110) are integrally formed. When the sealing tube (130) is inserted into or pulled out of the drug inlet, there will be no BHT exudate oozing out, that is, the O-ring is removed, which solves the problem of yellowing of the anesthetic due to the oozing of BHT exudate, so that the The user is able to use the medicine with greater confidence. In addition, the inner tube wall of the sealing tube (130), the surface of the connecting ring (120) facing the first tube end (111), and the outer tube wall of the drug introduction tube (110) opposite to the sealing tube (130) form together The pressure stabilization tank (101) is used to balance the air pressure in the container and the evaporator in an open state, so as to effectively reduce the insertion force between the drug introduction structure (100) and the evaporator, which is convenient for medical personnel to operate.
priorityDate 2017-06-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419493243
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID42113

Total number of triples: 20.